120 related articles for article (PubMed ID: 37161284)
1. LncRNA DLEU2 contributes to Taxol resistance of gastric cancer cells through regulating the miR-30c-5p-LDHA axis.
Xiang W; Zhang B; Li H
J Chemother; 2024 Feb; 36(1):49-60. PubMed ID: 37161284
[TBL] [Abstract][Full Text] [Related]
2. LncRNA-SNHG1 promotes paclitaxel resistance of gastric cancer cells through modulating the miR-216b-5p-hexokianse 2 axis.
Xu J; Xu Y; Ye G; Qiu J
J Chemother; 2023 Oct; 35(6):527-538. PubMed ID: 36548909
[TBL] [Abstract][Full Text] [Related]
3. lncRNA-DANCR Promotes Taxol Resistance of Prostate Cancer Cells through Modulating the miR-33b-5p-LDHA Axis.
Wang YY; Chen C
Dis Markers; 2022; 2022():9516774. PubMed ID: 35571619
[TBL] [Abstract][Full Text] [Related]
4. Long noncoding RNA HAGLR sponges miR-338-3p to promote 5-Fu resistance in gastric cancer through targeting the LDHA-glycolysis pathway.
Hu J; Huang L; Ding Q; Lv J; Chen Z
Cell Biol Int; 2022 Feb; 46(2):173-184. PubMed ID: 34658120
[TBL] [Abstract][Full Text] [Related]
5. Long noncoding RNA DLEU2 predicts a poor prognosis and enhances malignant properties in laryngeal squamous cell carcinoma through the miR-30c-5p/PIK3CD/Akt axis.
Li X; Xu F; Meng Q; Gong N; Teng Z; Xu R; Zhao M; Xia M
Cell Death Dis; 2020 Jun; 11(6):472. PubMed ID: 32555190
[TBL] [Abstract][Full Text] [Related]
6. Influences of the lncRNA TUG1-miRNA-34a-5p network on fibroblast-like synoviocytes (FLSs) dysfunction in rheumatoid arthritis through targeting the lactate dehydrogenase A (LDHA).
Zhang M; Lu N; Guo XY; Li HJ; Guo Y; Lu L
J Clin Lab Anal; 2021 Sep; 35(9):e23969. PubMed ID: 34403518
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA DLEU2 promotes the progression of esophageal cancer through miR-30e-5p/E2F7 axis.
Lu T; Wang R; Cai H; Cui Y
Biomed Pharmacother; 2020 Mar; 123():109650. PubMed ID: 31884338
[TBL] [Abstract][Full Text] [Related]
8. NORAD modulates miR-30c-5p-LDHA to protect lung endothelial cells damage.
Zhou Y; Chen C; Li Q; Sheng H; Guo X; Mao E
Open Med (Wars); 2022; 17(1):676-688. PubMed ID: 35480402
[TBL] [Abstract][Full Text] [Related]
9. lncRNA DLEU2 modulates cell proliferation and invasion of non-small cell lung cancer by regulating miR-30c-5p/SOX9 axis.
Zhou Y; Shi H; Du Y; Zhao G; Wang X; Li Q; Liu J; Ye L; Shen Z; Guo Y; Huang Y
Aging (Albany NY); 2019 Sep; 11(18):7386-7401. PubMed ID: 31541993
[TBL] [Abstract][Full Text] [Related]
10. lncRNA NEAT1 promotes the Taxol resistance of breast cancer via sponging the miR-23a-3p-FOXA1 axis.
Zhu L; Wang F; Fan W; Jin Z; Teng C; Zhang J
Acta Biochim Biophys Sin (Shanghai); 2021 Aug; 53(9):1198-1206. PubMed ID: 34327529
[TBL] [Abstract][Full Text] [Related]
11. LncRNA DLEU2 accelerates the tumorigenesis and invasion of non-small cell lung cancer by sponging miR-30a-5p.
Wu W; Zhao Y; Gao E; Li Y; Guo X; Zhao T; He W; Zhang H
J Cell Mol Med; 2020 Jan; 24(1):441-450. PubMed ID: 31721438
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of miR-138-5p Sensitizes Taxol-Resistant Epithelial Ovarian Cancer Cells through Targeting Cyclin-Dependent Kinase 6.
Liang M; Li Q; Shi S; Tian YN; Feng Y; Yang Y; Dong M; Zhang J; He J
Gynecol Obstet Invest; 2021; 86(6):533-541. PubMed ID: 34818258
[TBL] [Abstract][Full Text] [Related]
13. Blocking lncRNA-SNHG16 sensitizes gastric cancer cells to 5-Fu through targeting the miR-506-3p-PTBP1-mediated glucose metabolism.
Ding Y; Gao S; Zheng J; Chen X
Cancer Metab; 2022 Nov; 10(1):20. PubMed ID: 36447254
[TBL] [Abstract][Full Text] [Related]
14. Blocking lncRNA HCG18 re-sensitizes Taxol resistant lung cancer cells to Taxol through modulating the miR-34a-5p/HDAC1 axis.
Zhang F; Wang J; Li H; Luo X; Xu Q; Liu L; Xu Y; Yang K; Liu Z; Gong R
J Chemother; 2024 May; ():1-12. PubMed ID: 38706347
[TBL] [Abstract][Full Text] [Related]
15. LncRNA DLEU2 is activated by STAT1 and induces gastric cancer development via targeting miR-23b-3p/NOTCH2 axis and Notch signaling pathway.
Li G; Zhang Z; Chen Z; Liu B; Wu H
Life Sci; 2021 Jul; 277():119419. PubMed ID: 33785336
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic potential of ADSC-EV-derived lncRNA DLEU2: A novel molecular pathway in alleviating sepsis-induced lung injury via the miR-106a-5p/LXN axis.
He W; Xu C; Huang Y; Zhang Q; Chen W; Zhao C; Chen Y; Zheng D; XinyueLin ; Luo Q; Chen X; Zhang Z; Wu X; Huang J; Lin C; Huang Y; Zhang S
Int Immunopharmacol; 2024 Mar; 130():111519. PubMed ID: 38442573
[TBL] [Abstract][Full Text] [Related]
17. lncRNA DLEU2 Accelerates Oral Cancer Progression via miR-30a-5p/RAP1B Axis to Regulate p38 MAPK Signaling Pathway.
Zhang W; Wang Y; Xu P; Du Y; Guan W
Dis Markers; 2022; 2022():9310048. PubMed ID: 36277988
[TBL] [Abstract][Full Text] [Related]
18. LncRNA PVT1 Confers Cisplatin Resistance of Esophageal Cancer Cells through Modulating the miR-181a-5p-Glutaminase (GLS) Axis.
Chen Z; Wang Q; Huang L; Xu G; Hu J
Nutr Cancer; 2023; 75(8):1646-1657. PubMed ID: 37401860
[TBL] [Abstract][Full Text] [Related]
19. MiR-30c-5p suppresses migration, invasion and epithelial to mesenchymal transition of gastric cancer via targeting MTA1.
Cao JM; Li GZ; Han M; Xu HL; Huang KM
Biomed Pharmacother; 2017 Sep; 93():554-560. PubMed ID: 28686969
[TBL] [Abstract][Full Text] [Related]
20. Atractylodes-I Overcomes the Oxidative Stress-induced Colonic Mucosal Epithelial Cells Dysfunction to Prevent Irritable Bowel Syndrome
Xu R; Liu X; Tian M; Chen D
Curr Mol Med; 2023; 23(8):825-833. PubMed ID: 35959614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
